Tag Archives: Canada

World of Cannabis Interview: Tetra Bio Pharma

World of Cannabis Interview: Tetra Bio Pharma

World of Cannabis Interview: Tetra Bio Pharma

In this World of Cannabis interview, watch Caroline Cahill, Managing Editor of Marijuana Industry News, interview Ryan Brown, Co-founder of Tetra Bio Pharma.

Aphria

Aphria Continues Success Story With TSX Listing

LEAMINGTON, Ontario, March 21, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF), a Health Canada Licensed Producer of medical cannabis products, today announced that the common shares (the “Common Shares”) of the Company will begin trading on the Toronto Stock Exchange (“TSX”) as of the open of the market on March 22, 2017.

4 Reasons Your Marijuana Investment Could End in Tears

4 Reasons Your Marijuana Investment Could End in Tears

Marijuana has quickly become the next “can’t miss” investing idea for investors across North America. Despite this huge potential market, people are reluctant to put any of their cash into this market

Marijuana Markets on Both Sides of Niagara Falls

Marijuana Markets on Both Sides of Niagara Falls

The California Cannabis Business Expo wound down on March 8, closing with two panels at the Marijuana Investor Summit: one featuring the CEOs of three U.S. based firms active in the cannabis space; the other featuring four business and financial executives from Canada, who could speak to the state of the same industry in a very different legal and cultural context.

Marijuana Stocks Get Bounce After Dispensary Raids Throughout Canada

Marijuana Stocks Get Bounce After Dispensary Raids Throughout Canada

Publicly-traded marijuana companies had a rough week but got a bounce Thursday following news of raids at the Cannabis Culture dispensary chain owned by Marc and Jodie Emery.

Will the Opioid Crisis Derail Canada’s Recreational Cannabis Train?

Will the Opioid Crisis Derail Canada’s Recreational Cannabis Train?

Reports continue to emerge of young teens overdosing and sometimes dying due to the use of drugs containing fentanyl, a potent synthetic opioid. Smoking pot is different than popping pills, but the risk for the government is that the lines might get blurred quite quickly in the eyes of parents who are trying to protect their kids from the current opioid threat.

Study: Canadian Patients Substituting Marijuana for Prescription Drugs

Study: Canadian Patients Substituting Marijuana for Prescription Drugs

According to a study recently published by the International Journal of Drug Policy, patients in Canada are substituting marijuana for opioids, benzodiazepines and antidepressants for symptom relief from pain and mental health conditions.

icclogo

ICC Enters Into MOU and Presale Agreement With Emblem Corp. Setting in Motion a Framework for the Importation pf CBD Into Canada

VANCOUVER, British Columbia, Feb. 27, 2017 /Weed Wire/ — ICC International Cannabis Corporation (“ICC” or the “Company”) (TSXV: ICC) is pleased to announce that it has entered into a memorandum of understanding and presale agreement (the “MOU and Presale Agreement”) with Emblem Corp. (TSXV: EMC; OTCQB: EMMBF), who through a wholly-owned subsidiary, is a licensed producer of medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations overseen by Health Canada.

mymnutraceuticals

MYM Closes Acquisition of Majority Interest in Inspection-Stage Licensed Producer Application

VANCOUVER, British Columbia, Feb. 22, 2017 /Weed Wire/ — MYM Nutraceuticals Inc. (CSE:MYM) (the “Company” or “MYM”) is pleased to announce that it has completed its acquisition of a majority interest in Sublime Culture Inc. (“Sublime”) and its inspection-stage application to become a Licensed Producer of medical cannabis.

Canopy-Growth

Canopy Growth Corporation Renews Agreement with XIB Consulting Inc.

SMITH FALLS, Ontario, Feb. 17, 2017 /Weed Wire/ — Canopy Growth Corporation (TSX: WEED) (“Canopy Growth” or the “Corporation”) announced that it has renewed the engagement agreement (“agreement”) with XIB Consulting Inc. (“XIB”) that the Corporation announced on April 7, 2016 and subsequently renewed October 7, 2016.

2000px-government_of_canada_logo-svg

Parliamentary Secretary Bill Blair Launches Tour to Meet with Canadians to Discuss Cannabis Legalization and Regulation

TORONTO, Ontario, Feb. 16, 2017 /Weed Wire/ — Bill Blair, Parliamentary Secretary to the Minister of Justice and Attorney General of Canada Jody Wilson-Raybould, has started a cross-country tour to discuss the legalization and regulation of cannabis.

Tilray

Tilray Announces Medical Cannabis Export to New Zealand

NANAIMO, British Columbia, Feb. 14, 2017 /Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today announced that it has received necessary approvals in Canada and New Zealand to export medical cannabis to New Zealand.

Should Investors Consider Canopy Growth Corp.?

Should Investors Consider Canopy Growth Corp.?

Investors are incredibly excited about Canopy Growth Corporation. But we’re now looking at a situation where the stock has increased quite aggressively thanks mostly to the belief that the future is bright. And there are still many investors sitting on the sidelines wondering if they should consider this company.

Recent Trends Reveal Canadian Market Maturing Faster Than U.S.

Recent Trends Reveal Canadian Market Maturing Faster Than U.S.

“We are continuing to see Canadian companies invest in or acquire assets in U.S. cannabis markets […] looking to take advantage of increased demand abroad,” a Viridian Capital analyst says.

2000px-government_of_canada_logo-svg

Statement from Health Canada on the Testing of Cannabis for Medical Purposes for Unauthorized Pest Control Products

OTTAWA, Ontario, Feb. 7, 2017 /Weed Wire/ — Recently, two licensed producers of cannabis for medical purposes undertook voluntary recalls of cannabis products that contained low levels of prohibited pest control products (myclobutanil/bifenazate/pyrethrins).

Canada's First Authorized Licensee of 2017 Starts Cultivating

Canada’s First Authorized Licensee of 2017 Starts Cultivating

On Jan. 10, 2017, Health Canada authorized James E. Wagner Cultivation in Ontario to start cultivating medical cannabis, making it the 38th licensed producer in Canada and the first producer of 2017 licensed under the Access to Cannabis for Medical Purposes Regulations.

Loyalist College

Loyalist College Receives Approval From Health Canada to Provide Analysis of Medical Cannabis

Loyalist College has received approval from Health Canada for a Controlled Drugs and Substances Licence for the purpose of research and analysis using medical cannabis.

How Big Could the Opportunity Be for Marijuana Stocks in California?

How Big Could the Opportunity Be for Marijuana Stocks in California?

The market for marijuana is exploding as Americans overwhelmingly embrace legalization. Analysts are projecting tens of billions of dollars in future marijuana sales, making this an intriguing market for investors.

Maple-Leaf-Green-World

Maple Leaf Plans to Build a New Nevada Facility

CALGARY, Alberta, Jan. 20, 2017 /Weed Wire/ — Maple Leaf Green World (MGW-V) (“Maple Leaf” or the “Company”) is pleased to announce that, after careful consideration of other options, the Company intends to build a new facility for its Nevada operations, using the same site BioNeva Innovations of Henderson LLC (“BioNeva”) employed to obtain its cultivation permit (the “Permit”).

North Americans Spent $53.3 Billion on Marijuana in 2016

North Americans Spent $53.3 Billion on Marijuana in 2016

North Americans spent $53.3 billion on legal, illegal, and medical marijuana in 2016, according to a Jan. 17, 2017, release from Arcview Research Group. That’s more than people in the United States spent on McDonald’s and Starbucks combined.

Safety in Numbers Drives Canopy Growth Corp. Higher

Safety in Numbers Drives Canopy Growth Corp. Higher

U.S. estimates by investment bank Cowen and Company suggest cannabis sales will increase at a compound annual growth rate of 23% over the next decade to US$50 billion. In Canada, it’s estimated that 5.2 million Canadians will consume legalized pot annually by 2021.

Cannabis Firm to Pay $4 Million for Stake in Vancouver Biotech

Cannabis Firm to Pay $4 Million for Stake in Vancouver Biotech

Anandia Labs co-founder Jonathan Page agreed to sell 20% of his company to CannaRoyalty because he appreciates CannaRoyalty’s expertise in extraction and post-processing.

Veritas Pharma

Veritas Announces Private Placement

Veritas Pharma Inc. (the “Company”) (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), is pleased to announce that a non-brokered private placement offering of up to 9,090,910 units (“Units”) at a price of $0.22 per Unit for aggregate gross proceeds of up to $2,000,000 (the “Offering”).

Olympic Athlete Challenging US Travel Ban for Past Marijuana Use

Olympic Athlete Challenging US Travel Ban for Past Marijuana Use

Olympic snowboarder Ross Rebagliati wants to visit the United States to promote Ross’ Gold, his Canadian cannabis brand; however, with Rebagliati having admitted past marijuana use, U.S. Border Agents have used a border policy to prevent him from entering the country.

ArcView

North American Marijuana Sales to Top $20.2 Billion by 2021, Grew 30 Percent in 2016

OAKLAND, Calif., Jan. 3, 2016 /Weed Wire/ — Arcview Market Research, the leading publisher of cannabis market research, released a new 2016 North American cannabis market size estimate as well as projections for the market through 2021, while announcing the availability of presales of its 5th edition of the State of Legal Marijuana Markets Report.

Veterans Affairs Canada Outs Medical Marijuana Users in Mail

Veterans Affairs Canada Outs Medical Marijuana Users in Mail

On Dec. 30, 2016, Canadian Armed Forces veterans began reporting a privacy breach by Veterans Affairs Canada, as the VAC sent letters to veterans in the federal medical marijuana program with “RE: Cannabis for Medical Purposes” visible in the envelope window.

Canadian marijuana stocks regain momentum after Christmas

Canadian Marijuana Stocks Regain Momentum After Christmas

In the last few months, the medical marijuana growers have dominated the trading activity on the TSX Venture in terms of dollar volume almost exclusively, belying a persistent interest from investors in Canada and the United States.

North American Cannabis Industry Raised $1 Billion in 2016

North American Cannabis Industry Raised $1 Billion in 2016

Viridian Capital Advisors recently reported the global cannabis industry has raised more than $1 billion in 2016, according to Forbes. Most of the $1 billion-plus in capital investments was raised in the United States and Canada, with other countries contributing small amounts, Scott Greiper of Viridian said.


Page 1 of 512345
Top